Alphatec Holdings, Inc. (NASDAQ: ATEC) is a Healthcare company (Medical - Devices) with a market capitalization of $1.1B. The Maz Rating grades it against the other companies in its sector.
Alphatec Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.94, Alphatec Holdings, Inc. trades at 1.3x sales and 51.1x book value, with an EV/EBITDA of 49.2. Over the last twelve months it generated about $843M of revenue and a net loss of $87M. It runs a gross margin of 66.7%, an operating margin of -3.1% and a net margin of -10.3%. It shows return on equity of -547.2%, return on invested capital of -4.1% and a free cash flow yield of 0.5%. On the balance sheet: a debt-to-equity ratio of 27.88 and a current ratio of 2.36. Over the past 52 weeks the share price ranged from $6.71 to $23.29, with a beta of 0.78.
Alphatec Holdings, Inc. does not currently pay a dividend.
21 Wall Street analyst ratings cover the stock: 17 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Alphatec Holdings, Inc. (ATEC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 36.6% / 30% · (Cash+Inv) / Mkt Cap (36m) 5.35% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 36.6% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 5.35% / 33% · Receivables / Mkt Cap (36m) 7.42% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 36.6% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 5.35% / 33.33% · Receivables / Mkt Cap (24m) 7.42% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 72.1% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 15.7% / 33.33% · Receivables / Avg Assets (4Q) 13.6% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 68.7% / 33.33% · (Cash+ST Inv) / Total Assets 10.0% / 33.33% · (Cash+Recv) / Total Assets 23.9% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Alphatec Holdings, Inc. (ATEC) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Alphatec Holdings, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
Alphatec Holdings, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.